139 related articles for article (PubMed ID: 1394681)
21. The crystal structure and absolute configuration of the antitumor platinum complex trans(OH)-Pt(OH)2(malonato)(1R,2R-cyclohexanediamine).
Goto M; Hirose J; Noji M; Lee KI; Saito R; Kidani Y
Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):1022-4. PubMed ID: 1525931
[TBL] [Abstract][Full Text] [Related]
22. Shikimic acid complexes of platinum. Preparation, reactivity, and antitumor activity of (R,R-1,2-diaminocyclohexane) bis(shikimato) platinum(II). Evidence for a novel rearrangement involving platinum-carbon bond formation.
Farrell N; Roberts JD; Hacker MP
J Inorg Biochem; 1991 Jun; 42(4):237-46. PubMed ID: 1880505
[TBL] [Abstract][Full Text] [Related]
23. Platinum and palladium complexes containing ethylenediamine derivatives as carrier ligands and their antitumor activity.
Lee K; Tashiro T; Noji M
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):702-3. PubMed ID: 8004720
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biodistribution and antitumor activity of hematoporphyrin-platinum(II) conjugates.
Kim YS; Song R; Hyun Kim D; Jun MJ; Sohn YS
Bioorg Med Chem; 2003 Apr; 11(8):1753-60. PubMed ID: 12659761
[TBL] [Abstract][Full Text] [Related]
25. Platinum(II) complexes of 4-methoxy- and 4-chlorobenzoic acid hydrazides. Synthesis, characterization, and cytotoxic effect.
Dodoff N; Grancharov K; Spassovska N
J Inorg Biochem; 1995 Dec; 60(4):257-66. PubMed ID: 8530921
[TBL] [Abstract][Full Text] [Related]
26. A novel water-soluble heptaplatin analogue with improved antitumor activity and reduced toxicity.
Liu W; Chen X; Ye Q; Xu Y; Xie C; Xie M; Chang Q; Lou L
Inorg Chem; 2011 Jun; 50(12):5324-6. PubMed ID: 21598993
[TBL] [Abstract][Full Text] [Related]
27. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes.
Khokhar AR; al-Baker S; Shamsuddin S; Siddik ZH
J Med Chem; 1997 Jan; 40(1):112-6. PubMed ID: 9016335
[TBL] [Abstract][Full Text] [Related]
28. Preparation, characterization, and antitumor activity of water-soluble aminoalkanol platinum(II) complexes.
Khokhar AR; Xu QY; Newman RA; Siddik ZH
J Inorg Biochem; 1991 Jul; 43(1):57-63. PubMed ID: 1940901
[TBL] [Abstract][Full Text] [Related]
29. Murine anti-tumor activity of new water soluble platinum(II) complexes with reduced toxicity.
Talebian AH; Bensely D; Schein PS; Green D
Anticancer Drug Des; 1990 Nov; 5(4):371-8. PubMed ID: 2291775
[TBL] [Abstract][Full Text] [Related]
30. The synthesis, characterisation and cytotoxicity of bisintercalating (2,2':6',2''-terpyridine)platinum(II) complexes.
Harper BW; Aldrich-Wright JR
Dalton Trans; 2015 Jan; 44(1):87-96. PubMed ID: 25407567
[TBL] [Abstract][Full Text] [Related]
31. In vitro release of SM-11355, cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)] platinum(II) suspended in lipiodol.
Kishimoto S; Noguchi T; Yamaoka T; Fukushima S; Takeuchi Y
Biol Pharm Bull; 2000 May; 23(5):637-40. PubMed ID: 10823679
[TBL] [Abstract][Full Text] [Related]
32. Antitumor effects of a new lipophilic platinum compound, trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), in mice.
Saegusa Y; Eriguchi M; Kidani Y; Matsuzawa A; Takeda Y
Anticancer Res; 2001; 21(1A):245-52. PubMed ID: 11299742
[TBL] [Abstract][Full Text] [Related]
33. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.
Hacker MP; Khokhar AR; Brown DB; McCormack JJ; Krakoff IH
Cancer Res; 1985 Oct; 45(10):4748-53. PubMed ID: 4040806
[TBL] [Abstract][Full Text] [Related]
34. Activity of platinum(II) intercalating agents against murine leukemia L1210.
McFadyen WD; Wakelin LP; Roos IA; Leopold VA
J Med Chem; 1985 Aug; 28(8):1113-6. PubMed ID: 4020833
[TBL] [Abstract][Full Text] [Related]
35. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
Yoshida M; Khokhar AR; Siddik ZH
Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
[TBL] [Abstract][Full Text] [Related]
36. Relation between intracellular accumulation and cytotoxic activity of cis-[((1R, 2R)-1, 2-cyclohexanediamine-N, N')bis(myristato)]platinum(II) suspended in Lipiodol.
Kishimoto S; Ohtani A; Fukuda H; Fukushima S; Takeuchi Y
Biol Pharm Bull; 2003 May; 26(5):683-6. PubMed ID: 12736512
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antitumor activity of (diamine)platinum(II) complexes of benzylmalonate derivatives.
Lee YA; Chung YK; Sohn YS
J Inorg Biochem; 1997 Dec; 68(4):289-94. PubMed ID: 9397577
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of Pt(II) complexes containing D-glucuronate, D-gluconate, or their acetyl derivatives and evaluation of antitumor activity against murine leukemia L1210.
Noji M; Hanai M; Ohmori T; Tashiro T; Suzuki K; Kidani Y
Chem Pharm Bull (Tokyo); 1988 Sep; 36(9):3439-46. PubMed ID: 3240538
[No Abstract] [Full Text] [Related]
39. Glucose conjugated platinum(II) complex: antitumor superiority to oxaliplatin, combination effect and mechanism of action.
Li H; Gao X; Liu R; Wang Y; Zhang M; Fu Z; Mi Y; Wang Y; Yao Z; Gao Q
Eur J Med Chem; 2015 Aug; 101():400-8. PubMed ID: 26177447
[TBL] [Abstract][Full Text] [Related]
40. Antitumor platinum(II) complexes of N-monoalkyl 1R,2R-diamino-cyclohexanes with 3-(nitrooxy)cyclobutane-1,1-dicarboxylate as a leaving group.
Zhao J; Gou S; Xu G; Cheng L
Eur J Med Chem; 2014 Oct; 85():408-17. PubMed ID: 25108080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
